Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT02040402
Eligibility Criteria:
Inclusion Criteria:
Chinese infants born in Hong Kong
Exclusion Criteria:
(i)Previous administration of PCV7 or other pneumococcal vaccines
(ii)History of immunodeficiency
(iii)Known or suspected impairment of immunologic function including, but not limited to, clinically significant liver disease; diabetes mellitus; moderate to severe kidney impairment
(iv)Malignancy, other than squamous cell or basal cell skin cancer
(v)Autoimmune disease
(vi)History of asthma or reactive airways disease
(vii)Cardiovascular and pulmonary disorder, chronic metabolic disease (including diabetes), renal dysfunction or hemoglobinopathies requiring regular medical follow-up or hospitalization during the preceding year
(viii)Use of immunosuppressive medication
(ix)Receipt of blood products or immunoglobulin in the past 6 month
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Weeks
Maximum Age:
9 Weeks
Study:
NCT02040402
Study Brief:
Protocol Section:
NCT02040402